New Antibiotic, Manikomycin, Acts on Novel Ribosomal Target

Researchers discovered manikomycin, a novel antibiotic that kills drug-resistant bacteria by targeting a previously unknown ribosomal vulnerability. The breakthrough could lead to a new class of treatments against antimicrobial resistant bacteria.

The post New Antibiotic, Manikomycin, Acts on Novel Ribosomal Target appeared first on GEN - Genetic Engineering and Biotechnology News.